Surgical Innovations Group (SUN)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.55p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.90p
  • 52 Week Low: 0.40p
  • Currency: UK Pounds
  • Shares Issued: 932.82m
  • Volume: 37,500
  • Market Cap: £5.13m
  • RiskGrade: 341
  • Beta: 0.52

Surgical Innovations confirms CE mark certification for 'CELLIS' range

By Josh White

Date: Thursday 13 Sep 2018

LONDON (ShareCast) - (Sharecast News) - Innovative medical technology designer and manufacturer Surgical Innovations Group updated the market on the CELLIS range of products supplied to its UK distribution business, Elemental Healthcare, by Meccellis Biotech on Thursday.
The AIM-traded firm said that on 12 September, Elemental received confirmation from Meccellis that CE certification had been issued in respect of the full range of CELLIS products previously sold by Elemental, and also covering new products including the CELLIS Breast Pocket range launched at the London Breast meeting on 6 & 7 September 2018.

It said the certificates were valid until August 2023.

"Meccellis are now in a position to resume manufacture of these products, and detailed plans are in progress to facilitate a timely and controlled reintroduction to the UK market in coming weeks," the Surgical Innovations board said in its statement.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SUN Market Data

Currency UK Pounds
Share Price 0.55p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.90p
52 Week Low 0.40p
Volume 37,500
Shares Issued 932.82m
Market Cap £5.13m
Beta 0.52
RiskGrade 341

SUN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.66% above the market average60.66% above the market average60.66% above the market average60.66% above the market average60.66% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Price Trend
34.34% below the market average34.34% below the market average34.34% below the market average34.34% below the market average34.34% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average
Income Not Available
Growth
12.16% above the market average12.16% above the market average12.16% above the market average12.16% above the market average12.16% above the market average
5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SUN Dividends

No dividends found

Trades for 22-Nov-2024

Time Volume / Share Price
13:11 37,500 @ 0.50p

SUN Key Personnel

CEO David Marsh
Chair Jonathan Glenn

Top of Page